
Uniname Diagnostics Private Limited
About Uniname Diagnostics Private Limited
Data last updated:
Uniname Diagnostics Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 28 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85110MP2007PTC020033.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Meena Jain and Bharat Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 83 – A Sudama Nagar Opposite Chhatrapati Shivaji School, Indore, Madhya Pradesh, India – 452009.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.24 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹34,750 (net margin 1.6%) and EBITDA of ₹84,010 (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Uniname Diagnostics Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address83 – A Sudama Nagar Opposite Chhatrapati Shivaji School, Indore, Madhya Pradesh, India – 452009
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Uniname Diagnostics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uniname Diagnostics is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Uniname Diagnostics Private Limited, buy the company report.
Financials of Uniname Diagnostics Private Limited
FY 2025 filings availableUniname Diagnostics Private Limited reported revenue of ₹22.24 Lakh (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 13% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹84,010 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,750 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uniname Diagnostics Private Limited, buy the company report.
Board of directors of Uniname Diagnostics Private Limited
Uniname Diagnostics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena Jain | Director | 28 Nov 2007 | 18 Years 11 Months | Current |
| Bharat Shah Also directs: Uniname Medi-Hub Private Limited | Director | 28 Nov 2007 | 18 Years 11 Months | Current |
Auditor
Uniname Diagnostics Private Limited is audited by ABHAY KUMAR JAIN & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHAY KUMAR JAIN & CO | FY 2019 | 006386C |
Shareholding
The shareholding of Uniname Diagnostics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Uniname Diagnostics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Uniname Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uniname Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Uniname Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Uniname Diagnostics Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Kavita Jain ceased to be Director on 25 Mar 2015.
Frequently asked questions
Uniname Diagnostics is an active private limited company based in Indore, Madhya Pradesh, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 28 November 2007 (19+ years old) and is registered under CIN U85110MP2007PTC020033.
Uniname Diagnostics has 2 current directors:
- Meena Jain - Director
- Bharat Shah - Director
The latest financial statements of Uniname Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Uniname Diagnostics is U85110MP2007PTC020033. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uniname Diagnostics was incorporated on 28 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Gwalior.
Kavita Jain ceased to be Director on 25 Mar 2015. Bharat Shah was appointed as Director on 28 Nov 2007. Meena Jain was appointed as Director on 28 Nov 2007.
The registered office of Uniname Diagnostics is at 83 – A Sudama Nagar Opposite Chhatrapati Shivaji School, Indore, Madhya Pradesh, India – 452009.
Uniname Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
The compliance status of Uniname Diagnostics is compliant as of 22 July 2026. The company is actively filing with the Registrar of Companies.
Uniname Diagnostics can be reached at its registered office: 83 – A Sudama Nagar Opposite Chhatrapati Shivaji School, Indore, Madhya Pradesh, India – 452009.

